{"organizations": [], "uuid": "3e7c03310a531d89d5aa22197e4f534688a294b2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180111.html", "section_title": "Archive News &amp; Video for Thursday, 11 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fda-revises-labeling-for-prescript/brief-fda-revises-labeling-for-prescription-opioid-cough-medicines-in-children-below-18-years-idUSFWN1P60VI", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA Revises Labeling For Prescription Opioid Cough Medicines In Children Below 18 Years", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-01-12T01:48:00.000+02:00", "replies_count": 0, "uuid": "3e7c03310a531d89d5aa22197e4f534688a294b2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fda-revises-labeling-for-prescript/brief-fda-revises-labeling-for-prescription-opioid-cough-medicines-in-children-below-18-years-idUSFWN1P60VI", "ord_in_thread": 0, "title": "BRIEF-FDA Revises Labeling For Prescription Opioid Cough Medicines In Children Below 18 Years", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA SAYS IS REQUIRING SAFETY LABELING CHANGES TO LIMIT USE OF PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE IN CHILDREN BELOW 18 YRS\n* ‍U.S. FDA SAYS LABELING FOR PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE BEING UPDATED FOR ADULT USE, INCLUDING EXPANDED BOXED WARNING‍​​ Source text: ( bit.ly/2Ex6nUe )\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2Ex6nUe"], "published": "2018-01-12T01:48:00.000+02:00", "crawled": "2018-01-12T18:25:58.007+02:00", "highlightTitle": ""}